- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
-
- Sylvester Researchers Receive $9.5 Million Grant To Study Esophageal Cancer
- NCI To Fund Sylvester-Led Study On How Exercise And Nutrition May Improve Ovarian Cancer Outcomes
- Researchers At Sylvester, Frost School Receive $2.6M Federal Grant To Study Mindfulness And Music Therapy
- Tow Foundation Commits $2 Million To Multiple Myeloma Research At Sylvester
- Sylvester Researchers Receive $2M To Conduct Clinical Trial On Unique Immunotherapy
- $1.8 Million NIH Grant Supports Head And Neck Cancer Research
- Sylvester Researchers Receive $1.7 Million NIH Grant To Study Epigenetic Mechanisms In ER Breast Cancer
- New Research Highlights Racial Disparities In Genomic Profiling
- Partnership To Identify Novel Genetic Drivers Of Cancer Disparities In African Ancestry Populations
- Our Phase 1 Clinical Trials
- Investigator-Initiated Trials (IIT)
- The Lifestyle Intervention Of Food And Exercise For Lymphoma – The LIFE-L Study
-
- Sylvester Partners With PAHO WHO To Train Caribbean Clinicians In Mammography Quality Assurance
- Sylvester Rectal Cancer Program Receives Elite NAPRC Accreditation From American College Of Surgeons
- The Lancet Publishes Sylvester-LED Study Defining New Standard Of Care For Prostate Cancer Recurrence After Prostatectomy
- Sylvester Plays Pivotal Role In Practice-Changing Anal Cancer Prevention Study Published By Nejm
- Dr. Donald T. Weed Works To Bridge Global Disparities In Head And Neck Surgery, From Haiti To Africa
-
- Paving The Path To Greatness: A Decade Of Transformation And Commitment To Excellence Celebration Honors Dr. Dipen J. Parekh And Dr. Stephen D. Nimer
- Dr. Antonio Iavarone Joins Sylvester As New Deputy Director
- Dr. Alberto Caban-Martinez Joins Prestigious Occupational And Environmental Health Organization
- Sylvester Names Dr. Sophia George To Lead The Cancer Center’s Focus On Diversity, Equity, And Inclusion
- Sylvester Researcher Receives $5 Million NCI Merit Award For Brain Cancer Adaptive Therapy Study
- Ph.D. Candidate At Sylvester Receives Prestigious F31 NCI Grant
- Sylvester’s Lead Of Evidence Based Survivorship Supportive Care Receives ABMR Early-Stage Investigator Award
- Neurosurgeon Ashish Shah Returns To Sylvester To Head Clinical Trials And Translational Research On Brain Tumors
- Sylvester Pancreatic Cancer Researcher Dr. Nagaraj Nagathihalli Awarded Florida Department Of Health Grant
- Scott M. Welford, Ph.D. And Dr. Priyamvada Rai To Co-Lead Sylvester’s Tumor Biology
- Employees Who Go Above And Beyond At Sylvester Earn Special Recognition
-
- Surviving And Thriving
- Sylvester Goes To Capitol Hill In Support Of Comprehensive Cancer Survivorship Act
- Sylvester’s Sexual Health After Cancer Program Expands To Meet Needs Of Women With Cancer
- Sylvester Celebrates Inaugural Cancer Survivorship Symposium
- Young Cancer Survivors Share Experiences, Support At Sylvester’s Aya Summit
- Testicular Cancer Patient, Against All Odds, Is Now A Father
- New “Believe In You” Training Program To Help Cancer Survivors Live A Healthier Lifestyle
- Art Is Medicine
- Spreading The Holiday Spirit To Children At Alex´s Place
- Cancer Support by the Numbers
-
- First Lady Jill Biden Visits Sylvester Comprehensive Cancer Center To Spread Breast Cancer Awareness
- Sylvester Leaders Meet With White House Officials, Agencies About Reducing Cancer
- Sylvester Game Changer Vehicle Among First In Nation To Offer Mobile Prostate Cancer Screening
- Sylvester Hosts Fourth Annual National Firefighter Cancer Symposium
- Florida Academic Cancer Center Alliance Brings Cancer Researchers Together During Annual Retreat
- Sylvester Researchers Identify High Death Rate From Gastric Cancer In South Florida
-
- Dolphins Challenge Cancer XII Raised Record-Breaking $8.4 Million For Sylvester
- Steeped In Tradition And Ceremony
- Sylvester’s 30th Naming Anniversary Celebration Honors Family’s Philanthropy And Foresight
- The Pap Corps Celebrated 70th Anniversary Supporting Cancer Research
- Gift Establishes Eileen Youtie Predisposition Syndrome Initiative At Sylvester
- Janet And Mark Levy Recognized For Gift To Advance Cancer And Neurology Research
- Honoring A Promise
- Jernigan Family Funds Research And Therapy At Sylvester
- Our Donors in 2022
Sylvester Comprehensive Cancer Center has the only academic phase 1 clinical trials program in South Florida.
Before a new cancer treatment can be approved and become part of standard treatment, it must go through three different levels of evaluation called “phases.” The goal of phase 1 clinical trials is to determine the safety, early evidence, and efficacy of new treatments in patients with cancer. Phase 1 trials may help develop more treatment choices and most importantly, give hope, for hematology/oncology patients.
Phase 1 trials normally involve a small number of patients who are closely monitored by our research team. Each trial has its own risks and benefits. Participants can choose to quit a clinical trial at any time but should consult with their doctor first.
These are some of the questions that can help a potential participant decide if they will join a clinical trial at Sylvester Comprehensive Cancer Center:
- Why is this trial being done?
- How long will I be in the trial?
- What are the possible side effects of the experimental treatment?
- What are some possible benefits?
- How will we know if the treatment is working?
- Will my insurance cover any costs?
- How could this trial affect my daily life?
- Will I have to travel long distances to be a part of this study?
- What are my other treatment options?
- We carefully screen all potential participants to determine if they are eligible for the study. This is done to be sure the study is safe for you.
The research team at Sylvester is committed to finding a cure for cancer. We are both thankful for and honored by all the courageous patients who allow us to be a part of their care.